全球心臟人工智慧监测和诊断市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，心臟人工智慧监测和诊断市场规模将从 2025 年的 16.2 亿美元成长至 143.2 亿美元，2026 年至 2034 年的复合年增长率为 27.41%。

由于全球心血管疾病发生率不断上升，人工智慧驱动的心臟监测和诊断全球市场正快速成长。人工智慧能够有效率地分析大量心臟数据，进而提高诊断准确率。穿戴式装置的广泛应用和远端患者监护系统的实际部署进一步推动了市场成长。医疗服务提供者正越来越多地利用人工智慧进行早期检测并改善治疗效果。

关键驱动因素包括机器学习演算法的进步以及人工智慧与影像技术的融合。心臟病学领域对预测分析日益增长的需求有助于提高临床决策的准确性。远端医疗服务和数位健康平台的扩展也为市场发展提供了支持。医疗保健投资的增加以及监管机构对基于人工智慧的医疗解决方案的支持，进一步巩固了市场成长前景。

展望未来，即时监测和云端分析技术的持续创新将拓展应用范围。新兴经济体采用数位医疗基础设施将创造新的成长机会。人工智慧与先进成像和穿戴式技术的融合将改善预防医学。随着医疗系统日益重视数据驱动的诊断，心臟人工智慧解决方案有望广泛应用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球心臟人工智慧监测与诊断市场：按产品划分

• 市场分析、洞察与预测
• 硬体
• 软体解决方案
• 服务

第五章 全球心臟人工智慧监测与诊断市场：按类型划分

• 市场分析、洞察与预测
• 心臟诊断
• 心臟监测

第六章 全球心臟人工智慧监测与诊断市场：按应用领域划分

• 市场分析、洞察与预测
• 心律不整
• 中风
• 缺血性心臟疾病
• 狭窄
• 其他用途

第七章 全球心臟人工智慧监测与诊断市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 专科诊所
• 诊断中心
• 研究机构和学术机构

第八章 全球心臟人工智慧监测与诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • CardiAI Inc
  • Cleerly Inc
  • DiA Imaging Analysis Ltd
  • HeartVista Inc
  • IDOVEN
  • Koninklijke Philips NV
  • RSIP Vision
  • Tempus Labs Inc
  • UltraSight Ltd
  • Ultromics Limited
  • Viz.Ai Inc

The Cardiac AI Monitoring and Diagnostics Market size is expected to reach USD 14.32 Billion in 2034 from USD 1.62 Billion (2025) growing at a CAGR of 27.41% during 2026-2034.

The Global Cardiac AI Monitoring and Diagnostics Market is growing rapidly due to increasing cardiovascular disease prevalence worldwide. Artificial intelligence enhances diagnostic accuracy by analyzing large volumes of cardiac data efficiently. Rising adoption of wearable devices and remote patient monitoring systems further fuels market growth. Healthcare providers are increasingly leveraging AI to improve early detection and treatment outcomes.

Key drivers include advancements in machine learning algorithms and integration of AI with imaging technologies. Growing demand for predictive analytics in cardiology enhances clinical decision-making. Expansion of telehealth services and digital health platforms supports market development. Increased healthcare investments and regulatory support for AI-based medical solutions further strengthen growth prospects.

Looking ahead, continuous innovation in real-time monitoring and cloud-based analytics will expand applications. Emerging economies adopting digital health infrastructure will create new growth opportunities. Integration of AI with advanced imaging and wearable technology will improve preventive care. As healthcare systems focus on data-driven diagnostics, cardiac AI solutions are expected to gain widespread adoption.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Hardware
• Software solutions
• Services

By Type

• Cardiac diagnostics
• Cardiac monitoring

By Application

• Cardiac arrhythmias
• Stroke
• Ischemic heart disease
• Stenosis
• Other applications

By End-use

• Hospitals
• Specialty clinics
• Diagnostic centers
• Research and academic institute

COMPANIES PROFILED

• CardiAI Inc, Cleerly Inc, DiA Imaging Analysis Ltd, HeartVista Inc, IDOVEN, Koninklijke Philips NV, RSIP Vision, Tempus Labs Inc, UltraSight Ltd, Ultromics Limited, Vizai Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Hardware Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Software solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Cardiac diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiac monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cardiac arrhythmias Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ischemic heart disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Specialty clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Research and academic institute Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Type
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Type
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Type
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Type
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Type
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 CardiAI Inc
  • 10.2.2 Cleerly Inc
  • 10.2.3 DiA Imaging Analysis Ltd
  • 10.2.4 HeartVista Inc
  • 10.2.5 IDOVEN
  • 10.2.6 Koninklijke Philips N.V
  • 10.2.7 RSIP Vision
  • 10.2.8 Tempus Labs Inc
  • 10.2.9 UltraSight Ltd
  • 10.2.10 Ultromics Limited
  • 10.2.11 Viz.Ai Inc